Full Length Research Paper
References
AltintasÅŸ DU, Evliyaoglu N, Kilinc B, Sen'an DI, GüneÅŸer S (1996). The modification in measles vaccination age as a consequence of the earlier decline of transplacentally transferred antimeasles antibodies in Turkish infants. Eur. J. Epidemiol. 12(6):647-648. |
|
Centre for Disease Control and prevention (1999). Global measles control and regional elimination 1998-1999. MMWR Morb Mortal Wkly Rep. 48:1124-30. |
|
Cutts FT, Henao-Restrepo AM, Olive JM (1999). Measles elimination: progress and challenges. Vaccine 17:S47-S52. |
|
Cutts FT, Nyandu B, Markowitz LE, Forsey T, Zell ER, Othepa O, Wilkins K (1994). Immunogenicity of high-titre AIK-C or Edmonston-Zagreb vaccines in 3.5-month-old infants, and of medium-or high-titre Edmonston-Zagreb vaccine in 6-month-old infants, in Kinshasa, Zaire. Vaccine 12(14):1311-1316. |
|
De Quadros CA, Olivé JM, Hersh BS, Strassburg MA, Henderson DA, Brandling-Bennett D, Alleyne GA (1996). Measles elimination in the Americas: Evolving strategies. Jama, 275(3):224-229. |
|
Expanded Program on Immunization (1993). Global Advisory Group. II. Measles. Wkly Epidemiol Rec. 3:14. |
|
Federal Democratic Republic of Ethiopia (2008). Population Census Commission. Summary and Statistical Report of the 2007 Population and Housing Census, Population Size by Age and Sex. Addis Ababa, December; pp. 1-11. |
|
Federal Ministry of Health and WHO Ethiopia (2007). National guideline for measles surveillance and outbreak investigation. Addis Ababa, April, pp. 3, 22. |
|
Federal Ministry of Health Ethiopia (2010/2011). Measles pre-elimination in Ethiopia integrated measles immunization activity: A Field Guide.Addis Ababa. pp.10-11. |
|
FMOH (2009). Ethiopia. Public Health Emergency Management Guideline. December; P 22. |
|
FMOH (2010). Accelerated Measles Control in Ethiopia: Integrated Measles SIAs Field Guide. Revised August. P 6. |
|
Kiepiela P, Coovadia HM, Loening WE, Coward P, Abdool Karim SS (1991). Loss of maternal measles antibody in black South African infants in the first year of life: implications for age of vaccination. S. Afr. Med. J. 79(3):145-8. |
|
Nigatu W, Samuel D, Cohen B, Cumberland P, Lemma E, Brown DW, Nokes (2008). Evaluation of a measles vaccine campaign in Ethiopia using oral-fluid antibody surveys. Vaccine 26(37):4769-4774. |
|
Tades T, Ghlorghis B (1985). Measles immunity in children before one year of age: a pilot study. Ethiop. Med. J. 23:17-20. |
|
The Federal Ministry of Health of Ethiopia (2002). National Technical Guideline Integrated Disease Surveillance and Response (IDSR). Addis Ababa. First Edition September; Version 1.1:2-3. |
|
WHO (2005). Communicable disease control in emergencies; A field manual.Geneva;,pp 162 |
|
WHO (2008). Regional office for Africa. Technical Guidelines for Integrated diseases surveillance and response in the African region. Brazzaville, March; P 36. |
|
WHO-AFRO (2007). AFRO Measles Surveillance Feedback Bulletin; November. |
|
World Health Organization (2009). Measles and Rubella Surveillance and Outbreak Investigation Guidelines World Health Organization Regional Office for South-East Asia. P 19. |
|
World Health Organization Regional Office for Africa (2004). Guidelines for Measles Surveillance Revised December, P 3. |
Copyright © 2025 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0